Synopsis

Cardiovascular magnetic resonance (CMR) provides comprehensive characterization of the heart in patients with hypertrophic cardiomyopathy (HCM) including precise definition of left ventricular wall thickness and myocardial tissue characterization with late gadolinium enhancement (LGE). CMR contributes to the identification of patients at risk for sudden death including high risk features of LV apical aneurysms and extensive LGE. CMR in conjunction with current management strategies have resulted in a HCM becoming a treatable disease with low mortality rates.